CYAD logo

Celyad Oncology SA (CYAD) Earnings Per Share

Annual EPS

-$1.91
+$0.10+5.10%

December 31, 2022

Summary

Performance

1-Year Change

+5.1%

3-Year Change

+25.54%

5-Year Change

+71.24%

15-Year Change

+71.24%

CYAD EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$1.40

3-Year Low

-$2.01

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
CYAD previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
CYAD next annual earnings announcement has not yet been scheduled

OtherCYADprofitabilitymetrics:

Annual Revenue

-
CYAD annual revenue value is unknown

Annual Gross Profit

$0.00
CYAD annual gross profit is $0.00

Annual Operating Profit

-$21.37 M
CYAD annual operating income is -$21.37 million

Annual Net Income

-$43.17 M
CYAD annual net profit is -$43.17 million

Quarterly EPS

-$0.30
+$0.08+21.83%

June 30, 2022

Summary

Performance

3-Month Change

+21.83%

1-Year Change

+39.65%

3-Year Change

-

5-Year Change

-

CYAD Quarterly EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$0.42
CYAD quarterly earnings per share is currently -171.46% below its historical high of $0.42

3-Year Low

-$0.38

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CYAD previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CYAD next earnings announcement has not yet been scheduled

OtherCYADprofitabilitymetrics:

Quarterly Revenue

-
CYAD quarterly revenue value is unknown

Quarterly Gross Profit

$0.00
CYAD quarterly gross profit is $0.00

Quarterly Operating Profit

-$8.14 M
CYAD quarterly operating income is -$8.14 million

Quarterly Net Income

-$6.91 M
CYAD quarterly net profit is -$6.91 million

TTM EPS

-$1.47
+$0.20+11.73%

June 30, 2022

Summary

Performance

3-Month Change

+11.73%

1-Year Change

-16.25%

3-Year Change

-

5-Year Change

-

CYAD TTM EPS Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$0.04

3-Year Low

-$2.02

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2022
CYAD previous earnings announcement was published on Jun 30, 2022

Next Quarterly Earnings Report Date

N/A
CYAD next earnings announcement has not yet been scheduled

OtherCYADprofitabilitymetrics:

Annual Revenue

-
CYAD annual revenue value is unknown

Annual Gross Profit

$0.00
CYAD annual gross profit is $0.00

Annual Operating Profit

-$21.37 M
CYAD annual operating income is -$21.37 million

Annual Net Income

-$43.17 M
CYAD annual net profit is -$43.17 million

EPS Formula

EPS =  
Net Income - Preferred Dividends
Shares Outstanding

Annual EPS

-$1.91
CYAD annual earnings per share is -$1.91

Annual Net Income

-$43.17 M
CYAD annual net profit is -$43.17 million

Shares Outstanding

22.59 M
CYAD shares outstanding is 22.59 million

CYAD EPS Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.1%+39.6%-16.3%
3 y3 years+25.5%--
5 y5 years+71.2%--

CYAD EPS Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+5.4%+24.1%+27.9%at high+37.3%
5 y5-year+35.9%+34.3%-171.5%+146.5%+3699.2%+37.3%
alltimeall time+35.9%+247.7%-171.5%+146.5%+3699.2%+37.3%

Celyad Oncology SA EPS History

DateAnnualQuarterlyTTM
Dec 2022
-$1.91(-5.1%)
-
-
Jun 2022
-
-$0.30(-21.8%)
-$1.47(-11.7%)
Mar 2022
-
-$0.38(+58.8%)
-$1.67(-17.5%)
Dec 2021
-$2.01(+43.2%)
-$0.24(-56.7%)
-$2.02(+48.1%)
Sep 2021
-
-$0.55(+12.2%)
-$1.37(+7.7%)
Jun 2021
-
-$0.49(-32.8%)
-$1.27(+63.8%)
Mar 2021
-
-$0.74(-276.2%)
-$0.77(+1894.6%)
Dec 2020
-$1.40(-45.2%)
$0.42(-191.5%)
-$0.04(-91.5%)
Sep 2020
-
-$0.46
-$0.46
DateAnnualQuarterlyTTM
Dec 2019
-$2.56(-35.4%)
-
-
Dec 2018
-$3.97(-40.2%)
-
-
Dec 2017
-$6.64(+137.0%)
-
-
Dec 2016
-$2.80(-26.4%)
-
-
Dec 2015
-$3.81(+17.3%)
-
-
Dec 2014
-$3.24(-30.8%)
-
-
Dec 2013
-$4.69(+70.8%)
-
-
Dec 2012
-$2.75(+36.5%)
-
-
Dec 2011
-$2.01
-
-

FAQ

  • What is Celyad Oncology SA annual earnings per share?
  • What is the all time high annual EPS for Celyad Oncology SA?
  • What is Celyad Oncology SA annual EPS year-on-year change?
  • What is Celyad Oncology SA quarterly earnings per share?
  • What is the all time high quarterly EPS for Celyad Oncology SA?
  • What is Celyad Oncology SA quarterly EPS year-on-year change?
  • What is Celyad Oncology SA TTM earnings per share?
  • What is the all time high TTM EPS for Celyad Oncology SA?
  • What is Celyad Oncology SA TTM EPS year-on-year change?

What is Celyad Oncology SA annual earnings per share?

The current annual EPS of CYAD is -$1.91

What is the all time high annual EPS for Celyad Oncology SA?

Celyad Oncology SA all-time high annual earnings per share is -$1.40

What is Celyad Oncology SA annual EPS year-on-year change?

Over the past year, CYAD annual earnings per share has changed by +$0.10 (+5.10%)

What is Celyad Oncology SA quarterly earnings per share?

The current quarterly EPS of CYAD is -$0.30

What is the all time high quarterly EPS for Celyad Oncology SA?

Celyad Oncology SA all-time high quarterly earnings per share is $0.42

What is Celyad Oncology SA quarterly EPS year-on-year change?

Over the past year, CYAD quarterly earnings per share has changed by +$0.20 (+39.65%)

What is Celyad Oncology SA TTM earnings per share?

The current TTM EPS of CYAD is -$1.47

What is the all time high TTM EPS for Celyad Oncology SA?

Celyad Oncology SA all-time high TTM earnings per share is -$0.04

What is Celyad Oncology SA TTM EPS year-on-year change?

Over the past year, CYAD TTM earnings per share has changed by -$0.21 (-16.25%)